A Prospective, Clinical Study on Asymptomatic Sensitisation and Development of Allergic Rhinitis: High Negative Predictive Value of Allergological Testing

Background: Asymptomatic aeroallergen sensitisation affects approximately 10% of Western adolescents and is an established risk factor for the development of respiratory allergy. The reported incidence is 2–20% annually. Previous studies are based on out-seasonal symptom recollection or selected pop...

Full description

Saved in:
Bibliographic Details
Published inInternational archives of allergy and immunology Vol. 155; no. 3; pp. 289 - 296
Main Authors Bodtger, Uffe, Assing, Kristian, Poulsen, Lars K.
Format Journal Article
LanguageEnglish
Published Basel, Switzerland Karger 01.01.2011
Subjects
Online AccessGet full text
ISSN1018-2438
1423-0097
1423-0097
DOI10.1159/000320758

Cover

Abstract Background: Asymptomatic aeroallergen sensitisation affects approximately 10% of Western adolescents and is an established risk factor for the development of respiratory allergy. The reported incidence is 2–20% annually. Previous studies are based on out-seasonal symptom recollection or selected populations, conferring bias towards higher incidence rates. Objective: The aim was to determine the incidence of onset of symptoms among clinically well-characterised asymptomatic, sensitised subjects compared with controls, and to evaluate the predictive values of common allergological tests. Methods: We performed a prospective, clinical, non-interventional, 2-year follow-up study on subjects (identified by population screening) with seasonal allergic birch or grass pollen rhinitis (n = 52), asymptomatic sensitisation to grass or birch (AS, n = 52) or non-atopic, healthy control subjects (n = 39). Experimental allergen susceptibility was assessed at inclusion and at follow-up by skin prick test, conjunctival challenge, intradermal late-phase reaction and measurement of specific IgE. Participants completed in-seasonal symptom and medication diaries during 2 subsequent seasons. Results: We observed an annual incidence rate of 5% for the onset of symptoms in the AS group (healthy control group 0%). At baseline, the AS group displayed intermediate experimental allergen susceptibility. Subjects developing symptoms had higher levels of specific IgE and larger late-phase reaction than those persistently asymptomatic. However, the positive predictive values were low (14–27%) in contrast to the negative predictive values (95–100%). Conclusion: In a well-characterised young population, asymptomatic aeroallergen sensitisation conferred a low risk for onset of symptoms during the 2-year follow-up. Persistent asymptomatic phenotype could be accurately predicted by negative results from simple allergological testing.
AbstractList Background: Asymptomatic aeroallergen sensitisation affects approximately 10% of Western adolescents and is an established risk factor for the development of respiratory allergy. The reported incidence is 2–20% annually. Previous studies are based on out-seasonal symptom recollection or selected populations, conferring bias towards higher incidence rates. Objective: The aim was to determine the incidence of onset of symptoms among clinically well-characterised asymptomatic, sensitised subjects compared with controls, and to evaluate the predictive values of common allergological tests. Methods: We performed a prospective, clinical, non-interventional, 2-year follow-up study on subjects (identified by population screening) with seasonal allergic birch or grass pollen rhinitis (n = 52), asymptomatic sensitisation to grass or birch (AS, n = 52) or non-atopic, healthy control subjects (n = 39). Experimental allergen susceptibility was assessed at inclusion and at follow-up by skin prick test, conjunctival challenge, intradermal late-phase reaction and measurement of specific IgE. Participants completed in-seasonal symptom and medication diaries during 2 subsequent seasons. Results: We observed an annual incidence rate of 5% for the onset of symptoms in the AS group (healthy control group 0%). At baseline, the AS group displayed intermediate experimental allergen susceptibility. Subjects developing symptoms had higher levels of specific IgE and larger late-phase reaction than those persistently asymptomatic. However, the positive predictive values were low (14–27%) in contrast to the negative predictive values (95–100%). Conclusion: In a well-characterised young population, asymptomatic aeroallergen sensitisation conferred a low risk for onset of symptoms during the 2-year follow-up. Persistent asymptomatic phenotype could be accurately predicted by negative results from simple allergological testing.
Asymptomatic aeroallergen sensitisation affects approximately 10% of Western adolescents and is an established risk factor for the development of respiratory allergy. The reported incidence is 2-20% annually. Previous studies are based on out-seasonal symptom recollection or selected populations, conferring bias towards higher incidence rates.BACKGROUNDAsymptomatic aeroallergen sensitisation affects approximately 10% of Western adolescents and is an established risk factor for the development of respiratory allergy. The reported incidence is 2-20% annually. Previous studies are based on out-seasonal symptom recollection or selected populations, conferring bias towards higher incidence rates.The aim was to determine the incidence of onset of symptoms among clinically well-characterised asymptomatic, sensitised subjects compared with controls, and to evaluate the predictive values of common allergological tests.OBJECTIVEThe aim was to determine the incidence of onset of symptoms among clinically well-characterised asymptomatic, sensitised subjects compared with controls, and to evaluate the predictive values of common allergological tests.We performed a prospective, clinical, non-interventional, 2-year follow-up study on subjects (identified by population screening) with seasonal allergic birch or grass pollen rhinitis (n = 52), asymptomatic sensitisation to grass or birch (AS, n = 52) or non-atopic, healthy control subjects (n = 39). Experimental allergen susceptibility was assessed at inclusion and at follow-up by skin prick test, conjunctival challenge, intradermal late-phase reaction and measurement of specific IgE. Participants completed in-seasonal symptom and medication diaries during 2 subsequent seasons.METHODSWe performed a prospective, clinical, non-interventional, 2-year follow-up study on subjects (identified by population screening) with seasonal allergic birch or grass pollen rhinitis (n = 52), asymptomatic sensitisation to grass or birch (AS, n = 52) or non-atopic, healthy control subjects (n = 39). Experimental allergen susceptibility was assessed at inclusion and at follow-up by skin prick test, conjunctival challenge, intradermal late-phase reaction and measurement of specific IgE. Participants completed in-seasonal symptom and medication diaries during 2 subsequent seasons.We observed an annual incidence rate of 5% for the onset of symptoms in the AS group (healthy control group 0%). At baseline, the AS group displayed intermediate experimental allergen susceptibility. Subjects developing symptoms had higher levels of specific IgE and larger late-phase reaction than those persistently asymptomatic. However, the positive predictive values were low (14-27%) in contrast to the negative predictive values (95-100%).RESULTSWe observed an annual incidence rate of 5% for the onset of symptoms in the AS group (healthy control group 0%). At baseline, the AS group displayed intermediate experimental allergen susceptibility. Subjects developing symptoms had higher levels of specific IgE and larger late-phase reaction than those persistently asymptomatic. However, the positive predictive values were low (14-27%) in contrast to the negative predictive values (95-100%).In a well-characterised young population, asymptomatic aeroallergen sensitisation conferred a low risk for onset of symptoms during the 2-year follow-up. Persistent asymptomatic phenotype could be accurately predicted by negative results from simple allergological testing.CONCLUSIONIn a well-characterised young population, asymptomatic aeroallergen sensitisation conferred a low risk for onset of symptoms during the 2-year follow-up. Persistent asymptomatic phenotype could be accurately predicted by negative results from simple allergological testing.
Asymptomatic aeroallergen sensitisation affects approximately 10% of Western adolescents and is an established risk factor for the development of respiratory allergy. The reported incidence is 2-20% annually. Previous studies are based on out-seasonal symptom recollection or selected populations, conferring bias towards higher incidence rates. The aim was to determine the incidence of onset of symptoms among clinically well-characterised asymptomatic, sensitised subjects compared with controls, and to evaluate the predictive values of common allergological tests. We performed a prospective, clinical, non-interventional, 2-year follow-up study on subjects (identified by population screening) with seasonal allergic birch or grass pollen rhinitis (n = 52), asymptomatic sensitisation to grass or birch (AS, n = 52) or non-atopic, healthy control subjects (n = 39). Experimental allergen susceptibility was assessed at inclusion and at follow-up by skin prick test, conjunctival challenge, intradermal late-phase reaction and measurement of specific IgE. Participants completed in-seasonal symptom and medication diaries during 2 subsequent seasons. We observed an annual incidence rate of 5% for the onset of symptoms in the AS group (healthy control group 0%). At baseline, the AS group displayed intermediate experimental allergen susceptibility. Subjects developing symptoms had higher levels of specific IgE and larger late-phase reaction than those persistently asymptomatic. However, the positive predictive values were low (14-27%) in contrast to the negative predictive values (95-100%). In a well-characterised young population, asymptomatic aeroallergen sensitisation conferred a low risk for onset of symptoms during the 2-year follow-up. Persistent asymptomatic phenotype could be accurately predicted by negative results from simple allergological testing.
Background: Asymptomatic aeroallergen sensitisation affects approximately 10% of Western adolescents and is an established risk factor for the development of respiratory allergy. The reported incidence is 2-20% annually. Previous studies are based on out-seasonal symptom recollection or selected populations, conferring bias towards higher incidence rates. Objective: The aim was to determine the incidence of onset of symptoms among clinically well-characterised asymptomatic, sensitised subjects compared with controls, and to evaluate the predictive values of common allergological tests. Methods: We performed a prospective, clinical, non-interventional, 2-year follow-up study on subjects (identified by population screening) with seasonal allergic birch or grass pollen rhinitis (n = 52), asymptomatic sensitisation to grass or birch (AS, n = 52) or non-atopic, healthy control subjects (n = 39). Experimental allergen susceptibility was assessed at inclusion and at follow-up by skin prick test, conjunctival challenge, intradermal late-phase reaction and measurement of specific IgE. Participants completed in-seasonal symptom and medication diaries during 2 subsequent seasons. Results: We observed an annual incidence rate of 5% for the onset of symptoms in the AS group (healthy control group 0%). At baseline, the AS group displayed intermediate experimental allergen susceptibility. Subjects developing symptoms had higher levels of specific IgE and larger late-phase reaction than those persistently asymptomatic. However, the positive predictive values were low (14-27%) in contrast to the negative predictive values (95-100%). Conclusion: In a well-characterised young population, asymptomatic aeroallergen sensitisation conferred a low risk for onset of symptoms during the 2-year follow-up. Persistent asymptomatic phenotype could be accurately predicted by negative results from simple allergological testing. Copyright [copy 2011 S. Karger AG, Basel
Author Poulsen, Lars K.
Assing, Kristian
Bodtger, Uffe
Author_xml – sequence: 1
  givenname: Uffe
  surname: Bodtger
  fullname: Bodtger, Uffe
  email: uffe.bodtger@dadlnet.dk
– sequence: 2
  givenname: Kristian
  surname: Assing
  fullname: Assing, Kristian
– sequence: 3
  givenname: Lars K.
  surname: Poulsen
  fullname: Poulsen, Lars K.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24284970$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21293149$$D View this record in MEDLINE/PubMed
BookMark eNqFkVuL1TAUhYOMOBd98F0kLyKCdXbT9CT17XC8jDCoOKOvJU13O9G0qUk6cP6Kv9aci2dABJ-SsL-1FtnrlByNbkRCHufwKs_L6hwACgailPfISc5ZkQFU4ijdIZcZ44U8JqchfAdIsFw8IMcsZ1WR8-qE_FrSz96FCXU0t_iSrqwZjVaWXsW5XVM30mVYD1N0g4pG0yscg4kmpEcaqbGlb_AWrZsGHCN1HV1ai75P5JebZJTI1_TC9Df0I_Zqk5DSsDXbMPpN2RnvRM66fht9jSGasX9I7nfKBny0P8_I13dvr1cX2eWn9x9Wy8tMFwsRMyZ0pQViyQRKJSoum0Y1jHGADjRq3eq2AdkpobDhaQEAYqHKhWZSyrKrijPyfOc7efdzTtn1YIJGa9WIbg61lAUkMyj_TwrGOQgJiXy6J-dmwLaevBmUX9d_Fp-AZ3tAhfTnzqtRm3DHcSZ5JTZGL3acTi0Fj90ByaHelF8fyk_s-V-sNnHbVPTK2H8qnuwUP5Tv0R-89-Pfdtq6cw
CitedBy_id crossref_primary_10_1097_WOX_0b013e318232df96
crossref_primary_10_2500_ajra_2012_26_3790
crossref_primary_10_1016_j_anai_2013_02_010
crossref_primary_10_1183_09031936_00153013
crossref_primary_10_53529_2500_1175_2021_3_40_48
crossref_primary_10_1017_S0007114513001505
crossref_primary_10_2217_epi_13_68
crossref_primary_10_1111_all_13630
crossref_primary_10_1111_cea_12607
crossref_primary_10_1159_000322237
Cites_doi 10.1016%2Fj.jaci.2005.05.017
10.1016%2FS0091-6749%2897%2970170-2
10.1007%2FBF00453546
10.1111%2Fj.1398-9995.1998.tb03954.x
10.1111%2Fj.1365-2249.2008.03712.x
10.1111%2Fj.1398-9995.2009.02169.x
10.1046%2Fj.1365-2222.1999.00567.x
10.1034%2Fj.1398-9995.2000.00367.x
10.1034%2Fj.1398-9995.2002.1o3532.x
10.1111%2Fj.1398-9995.2006.01140.x
10.1046%2Fj.1398-9995.2003.00323.x
10.1111%2Fj.1398-9995.1984.tb01931.x
10.1067%2Fmai.2003.37
10.1016%2Fj.spinee.2008.11.002
10.1111%2Fj.1365-2222.2006.02594.x
10.2174%2F187152808786848405
10.1111%2Fj.1398-9995.2004.00457.x
10.1111%2Fj.1399-3038.2008.00805.x
10.1016%2F0021-8707%2858%2990009-1
10.1111%2Fj.1398-9995.1993.tb04756.x
10.1016%2F0304-3959%2893%2990079-5
10.1016%2F0021-8707%2869%2990024-0
10.1111%2Fj.1398-9995.2006.01280.x
10.1158%2F1055-9965.EPI-07-2629
10.1034%2Fj.1399-3038.2003.00024.x
10.1111%2Fj.1398-9995.2007.01517.x
10.1034%2Fj.1398-9995.2002.12945.x
10.1046%2Fj.1365-2222.2003.01611.x
10.1111%2Fj.1365-2222.1992.tb02829.x
10.1111%2Fj.1365-2222.2006.02435.x
10.1067%2Fmai.2000.108312
10.2500%2F108854194778816634
10.1111%2Fj.1398-9995.2006.01084.x
ContentType Journal Article
Copyright 2011 S. Karger AG, Basel
2015 INIST-CNRS
Copyright © 2011 S. Karger AG, Basel.
Copyright_xml – notice: 2011 S. Karger AG, Basel
– notice: 2015 INIST-CNRS
– notice: Copyright © 2011 S. Karger AG, Basel.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
H94
DOI 10.1159/000320758
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Immunology Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
DatabaseTitleList
MEDLINE - Academic
MEDLINE
AIDS and Cancer Research Abstracts
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1423-0097
EndPage 296
ExternalDocumentID 21293149
24284970
10_1159_000320758
320758
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Denmark
GeographicLocations_xml – name: Denmark
GroupedDBID ---
.55
.GJ
0R~
0~5
0~B
29J
30W
328
34G
36B
39C
3O-
3O.
3V.
4.4
53G
5GY
5RE
7X7
88E
8AO
8FE
8FH
8FI
8FJ
8G5
8UI
AAYIC
ABJNI
ABOCM
ABPAZ
ABUWG
ACGFS
ACPRK
ACPSR
ADAGL
ADBBV
AENEX
AEYAO
AFDXO
AFFNX
AFJJK
AFKRA
AFRAH
AHMBA
ALDHI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZPMC
AZQEC
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CYUIP
DU5
DWQXO
E0A
EBS
EJD
EMB
EMOBN
F5P
FB.
FYUFA
GNUQQ
GUQSH
HCIFZ
HMCUK
HZ~
IAO
IHR
IHW
INH
IY7
KUZGX
L7B
LK8
M1P
M2O
M7P
N9A
O1H
O9-
PQQKQ
PROAC
PSQYO
RIG
RKO
RXVBD
SV3
UJ6
UKHRP
X7M
ZGI
ZXP
AAYXX
ABBTS
ABWCG
ACQXL
AFSIO
AHFRZ
CITATION
ITC
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PUEGO
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
H94
ID FETCH-LOGICAL-c367t-27c9c7ee527e8a7948bbab22400f0ceccdcdb08fa7aeb45980076a56c28885f93
ISSN 1018-2438
1423-0097
IngestDate Thu Sep 04 20:04:30 EDT 2025
Fri Sep 05 07:55:05 EDT 2025
Mon Jul 21 05:55:13 EDT 2025
Mon Jul 21 09:18:11 EDT 2025
Wed Sep 10 04:47:41 EDT 2025
Thu Apr 24 22:52:30 EDT 2025
Thu Aug 29 12:04:42 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Sensitisation to allergens
Immunoglobulin E
Allergen challenge
Seasonal allergic rhinitis
Risk assessment
Allergy
Immunopathology
Nose disease
Rhinitis
IgE
Risk
Asymptomatic
Medical screening
Prospective
Immunology
Risk factor
Predictive value
ENT disease
Allergen
Provocation test
Language English
License Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
https://www.karger.com/Services/SiteLicenses
CC BY 4.0
Copyright © 2011 S. Karger AG, Basel.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c367t-27c9c7ee527e8a7948bbab22400f0ceccdcdb08fa7aeb45980076a56c28885f93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 21293149
PQID 872440780
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_883040005
crossref_citationtrail_10_1159_000320758
crossref_primary_10_1159_000320758
proquest_miscellaneous_872440780
pubmed_primary_21293149
pascalfrancis_primary_24284970
karger_primary_320758
PublicationCentury 2000
PublicationDate 2011-01-01
PublicationDateYYYYMMDD 2011-01-01
PublicationDate_xml – month: 01
  year: 2011
  text: 2011-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Basel, Switzerland
PublicationPlace_xml – name: Basel, Switzerland
– name: Basel
– name: Switzerland
PublicationTitle International archives of allergy and immunology
PublicationTitleAlternate Int Arch Allergy Immunol
PublicationYear 2011
Publisher Karger
Publisher_xml – name: Karger
References Dreborg S, Frew AJ: Allergen standardization and skin tests. Allergy 1993;48(suppl 14):49–82.10.1111%2Fj.1398-9995.1993.tb04756.x
Bodtger U, Poulsen LK, Malling HJ: Asymptomatic skin sensitization to birch predicts later development of birch pollen allergy in adults: a 3-year follow-up study. J Allergy Clin Immunol 2003;111:149–154.1253211110.1067%2Fmai.2003.37
Bodtger U, Poulsen LK, Jacobi HH, Malling HJ: The safety and efficacy of subcutaneous birch pollen immunotherapy – a one-year, randomised, double-blind, placebo-controlled study. Allergy 2002;57:297–305.1190635910.1034%2Fj.1398-9995.2002.1o3532.x
Schappi GF, Suphioglu C, Taylor PE, Knox RB: Concentrations of the major birch tree allergen Bet v 1 in pollen and respirable fine particles in the atmosphere. J Allergy Clin Immunol 1997;100:656–661.938929610.1016%2FS0091-6749%2897%2970170-2
Bodtger U, Poulsen LK, Linneberg A: Rhinitis symptoms and IgE sensitization as risk factors for development of later allergic rhinitis in adults. Allergy 2006;61:712–716.1667724010.1111%2Fj.1398-9995.2006.01140.x
Altman DG: Practical Statistics for Medical Research, ed 1. New York, Chapman & Hall, 1992.
Rasmussen A, Sommer J: Pollen: how are the pollen counts performed. Copenhagen, Danish Meteorological Institute, 2010. http://www.dmi.dk/eng/index/research_and_development/pollen-4.htm.
Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T, Braun W: Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004;59:498–504.1508083010.1111%2Fj.1398-9995.2004.00457.x
Bodtger U, Jacobsen CR, Poulsen LK, Malling HJ: Long-term repeatability of the skin prick test is high when supported by history or allergen-sensitivity tests: a prospective clinical study. Allergy 2003;58:1180–1186.1461613110.1046%2Fj.1398-9995.2003.00323.x
Grow MH, Herman NB: Intracutaneous test in normal individuals. J Allergy 1935;36:108–111.
Remes ST, Korppi M, Kajosaari M, Koivikko A, Soininen L, Pekkanen J: Prevalence of allergic rhinitis and atopic dermatitis among children in four regions of Finland. Allergy 1998;53:682–689.970003710.1111%2Fj.1398-9995.1998.tb03954.x
Bodtger U, Poulsen LK, Malling HJ: Retrospective assessment of seasonal allergic symptoms: over-rating but useful. Clin Exp Allergy 2003;33:496–500.1268086610.1046%2Fj.1365-2222.2003.01611.x
Beese A, Morley S: Memory for acute pain experience is specifically inaccurate but generally reliable. Pain 1993;53:183–189.833698810.1016%2F0304-3959%2893%2990079-5
Winther L, Malling HJ, Moseholm L, Mosbech H: Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. 1. Efficacy estimated by a model reducing the bias of annual differences in pollen counts. Allergy 2000;55:818–826.1100344510.1034%2Fj.1398-9995.2000.00367.x
Linneberg A, Nielsen NH, Madsen F, Frolund L, Dirksen A, Jorgensen T: Increasing prevalence of specific IgE to aeroallergens in an adult population: two cross-sectional surveys 8 years apart. The Copenhagen Allergy Study. J Allergy Clin Immunol 2000;106:247–252.1093206610.1067%2Fmai.2000.108312
Rasmussen A: Pollen counts in Copenhagen, Denmark: archive data, 1978–2007. Danish Meteorological Institute. 2010. http://www.dmi.dk/dmi/index/viden/pollen/pollenoversigt-totaler.htm.
Pucci S, Incorvaia C: Allergy as an organ and a systemic disease. Clin Exp Immunol 2008;153(suppl 1):1–2.1872132010.1111%2Fj.1365-2249.2008.03712.x
Hagy GW, Settipane GA: Bronchial asthma, allergic rhinitis, and allergy skin tests among college students. J Allergy 1969;44:323–332.526188510.1016%2F0021-8707%2869%2990024-0
Radcliffe MJ, Lewith GT, Prescott P, Church MK, Holgate ST: Do skin prick and conjunctival provocation tests predict symptom severity in seasonal allergic rhinoconjunctivitis? Clin Exp Allergy 2006;36:1488–1493.1717767110.1111%2Fj.1365-2222.2006.02594.x
Don AS, Carragee EJ: Is the self-reported history accurate in patients with persistent axial pain after a motor vehicle accident? Spine J 2009;9:4–12.1911125810.1016%2Fj.spinee.2008.11.002
Bousquet PJ, Burbach G, Heinzerling LM, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet-Rouanet L, Demoly P, Bresciani M, Bruno A, Gjomarkaj M, Canonica GW, Darsow U, Durham S, Fokkens WJ, Giavi S, Gramiccioni C, Papadopoulos NG, Haahtela T, Kowalski ML, Magyar P, Murakozi G, Orosz M, Rohnelt C, Stingl G, Todo-Bom A, von Mutius E, Wiesner A, Wohrl S, Bousquet J, Zuberbier T: GA2LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients. Allergy 2009;64:1656–1662.1982488710.1111%2Fj.1398-9995.2009.02169.x
Assing K, Nielsen CH, Poulsen LK: Immunological characteristics of subjects with asymptomatic skin sensitization to birch and grass pollen. Clin Exp Allergy 2006;36:283–292.1649963810.1111%2Fj.1365-2222.2006.02435.x
Assing K, Bodtger U, Poulsen LK, Malling HJ: Grass pollen symptoms interfere with the recollection of birch pollen symptoms – a prospective study of suspected, asymptomatic skin sensitization. Allergy 2007;62:373–377.1736224710.1111%2Fj.1398-9995.2006.01280.x
Schäfer T, Hoelscher B, Adam H, Ring J, Wichmann HE, Heinrich J: Hay fever and predictive value of prick test and specific IgE antibodies: a prospective study in children. Pediatr Allergy Immunol 2003;14:120–129.1267575810.1034%2Fj.1399-3038.2003.00024.x
Riedinger F, Kuehr J, Strauch E, Schulz H, Ihorst G, Forster J: Natural history of hay fever and pollen sensitization, and doctors’ diagnosis of hay fever and pollen asthma in German schoolchildren. Allergy 2002;57:488–492.1202811310.1034%2Fj.1398-9995.2002.12945.x
Chambers VV, Glaser J: The incidence of subsequent ragweed pollinosis in symptom-free persons having positive reactions to ragweed pollen extract. J Allergy 1958;29:249–257.1353861910.1016%2F0021-8707%2858%2990009-1
Horak F: Manifestation of allergic rhinitis in latent-sensitized patients. A prospective study. Arch Otorhinolaryngol 1985;242:239–245.407418210.1007%2FBF00453546
Nouri-Aria KT, Durham SR: Regulatory T cells and allergic disease. Inflamm Allergy Drug Targets 2008;7:237–252.1907578910.2174%2F187152808786848405
Assing K, Bodtger U, Poulsen LK: Seasonal dynamics of chemokine receptors and CD62L in subjects with asymptomatic skin sensitization to birch and grass pollen. Allergy 2006;61:759–768.1667724710.1111%2Fj.1398-9995.2006.01084.x
Rauscher GH, Johnson TP, Cho YI, Walk JA: Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008;17:748–757.1838146810.1158%2F1055-9965.EPI-07-2629
Schäfer Y, Schäfer T, Meisinger C, Wichmann HE, Heinrich J: Predictivity of allergic sensitization (RAST) for the onset of allergic diseases in adults. Allergy 2008;63:81–86.1805301710.1111%2Fj.1398-9995.2007.01517.x
Arbes SJ Jr, Gergen PJ, Elliott L, Zeldin DC: Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 2005;116:377–383.1608379310.1016%2Fj.jaci.2005.05.017
Schappi GF, Taylor PE, Pain MC, Cameron PA, Dent AW, Staff IA, Suphioglu C: Concentrations of major grass group 5 allergens in pollen grains and atmospheric particles: implications for hay fever and allergic asthma sufferers sensitized to grass pollen allergens. Clin Exp Allergy 1999;29:633–641.1023132310.1046%2Fj.1365-2222.1999.00567.x
Govaere E, Van Gysel D, Verhamme KM, Doli E, De Baets F: The association of allergic symptoms with sensitization to inhalant allergens in childhood. Pediatr Allergy Immunol 2009;20:448–457.1917588810.1111%2Fj.1399-3038.2008.00805.x
Moller C, Bjorksten B, Nilsson G, Dreborg S: The precision of the conjunctival provocation test. Allergy 1984;39:37–41.669620910.1111%2Fj.1398-9995.1984.tb01931.x
Settipane RJ, Hagy GW, Settipane GA: Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc 1994;15:21–25.800545210.2500%2F108854194778816634
Kuehr J, Karmaus W, Frischer T, Hendel-Kramer A, Weiss K, Moseler M, Stephan V, Forster J, Urbanek R: Longitudinal variability of skin prick test results. Clin Exp Allergy 1992;22:839–844.142294110.1111%2Fj.1365-2222.1992.tb02829.x
ref13
ref12
ref15
ref14
ref31
ref30
ref11
ref33
ref10
ref32
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
21293139 - Int Arch Allergy Immunol. 2011;155(3):189-90
References_xml – reference: Govaere E, Van Gysel D, Verhamme KM, Doli E, De Baets F: The association of allergic symptoms with sensitization to inhalant allergens in childhood. Pediatr Allergy Immunol 2009;20:448–457.1917588810.1111%2Fj.1399-3038.2008.00805.x
– reference: Assing K, Bodtger U, Poulsen LK, Malling HJ: Grass pollen symptoms interfere with the recollection of birch pollen symptoms – a prospective study of suspected, asymptomatic skin sensitization. Allergy 2007;62:373–377.1736224710.1111%2Fj.1398-9995.2006.01280.x
– reference: Winther L, Malling HJ, Moseholm L, Mosbech H: Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. 1. Efficacy estimated by a model reducing the bias of annual differences in pollen counts. Allergy 2000;55:818–826.1100344510.1034%2Fj.1398-9995.2000.00367.x
– reference: Nouri-Aria KT, Durham SR: Regulatory T cells and allergic disease. Inflamm Allergy Drug Targets 2008;7:237–252.1907578910.2174%2F187152808786848405
– reference: Bodtger U, Jacobsen CR, Poulsen LK, Malling HJ: Long-term repeatability of the skin prick test is high when supported by history or allergen-sensitivity tests: a prospective clinical study. Allergy 2003;58:1180–1186.1461613110.1046%2Fj.1398-9995.2003.00323.x
– reference: Dreborg S, Frew AJ: Allergen standardization and skin tests. Allergy 1993;48(suppl 14):49–82.10.1111%2Fj.1398-9995.1993.tb04756.x
– reference: Hagy GW, Settipane GA: Bronchial asthma, allergic rhinitis, and allergy skin tests among college students. J Allergy 1969;44:323–332.526188510.1016%2F0021-8707%2869%2990024-0
– reference: Settipane RJ, Hagy GW, Settipane GA: Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc 1994;15:21–25.800545210.2500%2F108854194778816634
– reference: Assing K, Bodtger U, Poulsen LK: Seasonal dynamics of chemokine receptors and CD62L in subjects with asymptomatic skin sensitization to birch and grass pollen. Allergy 2006;61:759–768.1667724710.1111%2Fj.1398-9995.2006.01084.x
– reference: Beese A, Morley S: Memory for acute pain experience is specifically inaccurate but generally reliable. Pain 1993;53:183–189.833698810.1016%2F0304-3959%2893%2990079-5
– reference: Linneberg A, Nielsen NH, Madsen F, Frolund L, Dirksen A, Jorgensen T: Increasing prevalence of specific IgE to aeroallergens in an adult population: two cross-sectional surveys 8 years apart. The Copenhagen Allergy Study. J Allergy Clin Immunol 2000;106:247–252.1093206610.1067%2Fmai.2000.108312
– reference: Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T, Braun W: Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004;59:498–504.1508083010.1111%2Fj.1398-9995.2004.00457.x
– reference: Chambers VV, Glaser J: The incidence of subsequent ragweed pollinosis in symptom-free persons having positive reactions to ragweed pollen extract. J Allergy 1958;29:249–257.1353861910.1016%2F0021-8707%2858%2990009-1
– reference: Kuehr J, Karmaus W, Frischer T, Hendel-Kramer A, Weiss K, Moseler M, Stephan V, Forster J, Urbanek R: Longitudinal variability of skin prick test results. Clin Exp Allergy 1992;22:839–844.142294110.1111%2Fj.1365-2222.1992.tb02829.x
– reference: Bodtger U, Poulsen LK, Linneberg A: Rhinitis symptoms and IgE sensitization as risk factors for development of later allergic rhinitis in adults. Allergy 2006;61:712–716.1667724010.1111%2Fj.1398-9995.2006.01140.x
– reference: Schappi GF, Suphioglu C, Taylor PE, Knox RB: Concentrations of the major birch tree allergen Bet v 1 in pollen and respirable fine particles in the atmosphere. J Allergy Clin Immunol 1997;100:656–661.938929610.1016%2FS0091-6749%2897%2970170-2
– reference: Radcliffe MJ, Lewith GT, Prescott P, Church MK, Holgate ST: Do skin prick and conjunctival provocation tests predict symptom severity in seasonal allergic rhinoconjunctivitis? Clin Exp Allergy 2006;36:1488–1493.1717767110.1111%2Fj.1365-2222.2006.02594.x
– reference: Bousquet PJ, Burbach G, Heinzerling LM, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet-Rouanet L, Demoly P, Bresciani M, Bruno A, Gjomarkaj M, Canonica GW, Darsow U, Durham S, Fokkens WJ, Giavi S, Gramiccioni C, Papadopoulos NG, Haahtela T, Kowalski ML, Magyar P, Murakozi G, Orosz M, Rohnelt C, Stingl G, Todo-Bom A, von Mutius E, Wiesner A, Wohrl S, Bousquet J, Zuberbier T: GA2LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients. Allergy 2009;64:1656–1662.1982488710.1111%2Fj.1398-9995.2009.02169.x
– reference: Rasmussen A: Pollen counts in Copenhagen, Denmark: archive data, 1978–2007. Danish Meteorological Institute. 2010. http://www.dmi.dk/dmi/index/viden/pollen/pollenoversigt-totaler.htm.
– reference: Horak F: Manifestation of allergic rhinitis in latent-sensitized patients. A prospective study. Arch Otorhinolaryngol 1985;242:239–245.407418210.1007%2FBF00453546
– reference: Pucci S, Incorvaia C: Allergy as an organ and a systemic disease. Clin Exp Immunol 2008;153(suppl 1):1–2.1872132010.1111%2Fj.1365-2249.2008.03712.x
– reference: Schappi GF, Taylor PE, Pain MC, Cameron PA, Dent AW, Staff IA, Suphioglu C: Concentrations of major grass group 5 allergens in pollen grains and atmospheric particles: implications for hay fever and allergic asthma sufferers sensitized to grass pollen allergens. Clin Exp Allergy 1999;29:633–641.1023132310.1046%2Fj.1365-2222.1999.00567.x
– reference: Schäfer Y, Schäfer T, Meisinger C, Wichmann HE, Heinrich J: Predictivity of allergic sensitization (RAST) for the onset of allergic diseases in adults. Allergy 2008;63:81–86.1805301710.1111%2Fj.1398-9995.2007.01517.x
– reference: Schäfer T, Hoelscher B, Adam H, Ring J, Wichmann HE, Heinrich J: Hay fever and predictive value of prick test and specific IgE antibodies: a prospective study in children. Pediatr Allergy Immunol 2003;14:120–129.1267575810.1034%2Fj.1399-3038.2003.00024.x
– reference: Moller C, Bjorksten B, Nilsson G, Dreborg S: The precision of the conjunctival provocation test. Allergy 1984;39:37–41.669620910.1111%2Fj.1398-9995.1984.tb01931.x
– reference: Altman DG: Practical Statistics for Medical Research, ed 1. New York, Chapman & Hall, 1992.
– reference: Bodtger U, Poulsen LK, Jacobi HH, Malling HJ: The safety and efficacy of subcutaneous birch pollen immunotherapy – a one-year, randomised, double-blind, placebo-controlled study. Allergy 2002;57:297–305.1190635910.1034%2Fj.1398-9995.2002.1o3532.x
– reference: Grow MH, Herman NB: Intracutaneous test in normal individuals. J Allergy 1935;36:108–111.
– reference: Don AS, Carragee EJ: Is the self-reported history accurate in patients with persistent axial pain after a motor vehicle accident? Spine J 2009;9:4–12.1911125810.1016%2Fj.spinee.2008.11.002
– reference: Rasmussen A, Sommer J: Pollen: how are the pollen counts performed. Copenhagen, Danish Meteorological Institute, 2010. http://www.dmi.dk/eng/index/research_and_development/pollen-4.htm.
– reference: Bodtger U, Poulsen LK, Malling HJ: Asymptomatic skin sensitization to birch predicts later development of birch pollen allergy in adults: a 3-year follow-up study. J Allergy Clin Immunol 2003;111:149–154.1253211110.1067%2Fmai.2003.37
– reference: Bodtger U, Poulsen LK, Malling HJ: Retrospective assessment of seasonal allergic symptoms: over-rating but useful. Clin Exp Allergy 2003;33:496–500.1268086610.1046%2Fj.1365-2222.2003.01611.x
– reference: Rauscher GH, Johnson TP, Cho YI, Walk JA: Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008;17:748–757.1838146810.1158%2F1055-9965.EPI-07-2629
– reference: Riedinger F, Kuehr J, Strauch E, Schulz H, Ihorst G, Forster J: Natural history of hay fever and pollen sensitization, and doctors’ diagnosis of hay fever and pollen asthma in German schoolchildren. Allergy 2002;57:488–492.1202811310.1034%2Fj.1398-9995.2002.12945.x
– reference: Assing K, Nielsen CH, Poulsen LK: Immunological characteristics of subjects with asymptomatic skin sensitization to birch and grass pollen. Clin Exp Allergy 2006;36:283–292.1649963810.1111%2Fj.1365-2222.2006.02435.x
– reference: Remes ST, Korppi M, Kajosaari M, Koivikko A, Soininen L, Pekkanen J: Prevalence of allergic rhinitis and atopic dermatitis among children in four regions of Finland. Allergy 1998;53:682–689.970003710.1111%2Fj.1398-9995.1998.tb03954.x
– reference: Arbes SJ Jr, Gergen PJ, Elliott L, Zeldin DC: Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 2005;116:377–383.1608379310.1016%2Fj.jaci.2005.05.017
– ident: ref11
  doi: 10.1016%2Fj.jaci.2005.05.017
– ident: ref21
  doi: 10.1016%2FS0091-6749%2897%2970170-2
– ident: ref8
  doi: 10.1007%2FBF00453546
– ident: ref24
  doi: 10.1111%2Fj.1398-9995.1998.tb03954.x
– ident: ref33
  doi: 10.1111%2Fj.1365-2249.2008.03712.x
– ident: ref13
  doi: 10.1111%2Fj.1398-9995.2009.02169.x
– ident: ref22
  doi: 10.1046%2Fj.1365-2222.1999.00567.x
– ident: ref23
  doi: 10.1034%2Fj.1398-9995.2000.00367.x
– ident: ref17
  doi: 10.1034%2Fj.1398-9995.2002.1o3532.x
– ident: ref2
  doi: 10.1111%2Fj.1398-9995.2006.01140.x
– ident: ref29
  doi: 10.1046%2Fj.1398-9995.2003.00323.x
– ident: ref20
  doi: 10.1111%2Fj.1398-9995.1984.tb01931.x
– ident: ref7
  doi: 10.1067%2Fmai.2003.37
– ident: ref27
  doi: 10.1016%2Fj.spinee.2008.11.002
– ident: ref31
  doi: 10.1111%2Fj.1365-2222.2006.02594.x
– ident: ref32
  doi: 10.2174%2F187152808786848405
– ident: ref18
  doi: 10.1111%2Fj.1398-9995.2004.00457.x
– ident: ref1
  doi: 10.1111%2Fj.1399-3038.2008.00805.x
– ident: ref9
  doi: 10.1016%2F0021-8707%2858%2990009-1
– ident: ref19
  doi: 10.1111%2Fj.1398-9995.1993.tb04756.x
– ident: ref26
  doi: 10.1016%2F0304-3959%2893%2990079-5
– ident: ref10
  doi: 10.1016%2F0021-8707%2869%2990024-0
– ident: ref14
  doi: 10.1111%2Fj.1398-9995.2006.01280.x
– ident: ref28
  doi: 10.1158%2F1055-9965.EPI-07-2629
– ident: ref4
  doi: 10.1034%2Fj.1399-3038.2003.00024.x
– ident: ref3
  doi: 10.1111%2Fj.1398-9995.2007.01517.x
– ident: ref6
  doi: 10.1034%2Fj.1398-9995.2002.12945.x
– ident: ref25
  doi: 10.1046%2Fj.1365-2222.2003.01611.x
– ident: ref30
  doi: 10.1111%2Fj.1365-2222.1992.tb02829.x
– ident: ref12
  doi: 10.1111%2Fj.1365-2222.2006.02435.x
– ident: ref15
  doi: 10.1067%2Fmai.2000.108312
– ident: ref5
  doi: 10.2500%2F108854194778816634
– ident: ref16
  doi: 10.1111%2Fj.1398-9995.2006.01084.x
– reference: 21293139 - Int Arch Allergy Immunol. 2011;155(3):189-90
SSID ssj0015986
Score 1.9942454
Snippet Background: Asymptomatic aeroallergen sensitisation affects approximately 10% of Western adolescents and is an established risk factor for the development of...
Asymptomatic aeroallergen sensitisation affects approximately 10% of Western adolescents and is an established risk factor for the development of respiratory...
SourceID proquest
pubmed
pascalfrancis
crossref
karger
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 289
SubjectTerms Adult
Allergens - immunology
Betula - immunology
Biological and medical sciences
Denmark - epidemiology
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Humans
Immunoglobulin E - blood
Immunopathology
Incidence
Male
Medical sciences
Middle Aged
Non tumoral diseases
Original Paper
Otorhinolaryngology. Stomatology
Poaceae - immunology
Pollen - immunology
Predictive Value of Tests
Prospective Studies
Rhinitis, Allergic, Seasonal - diagnosis
Rhinitis, Allergic, Seasonal - epidemiology
Rhinitis, Allergic, Seasonal - immunology
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Sensitivity and Specificity
Skin Tests
Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology
Young Adult
Title A Prospective, Clinical Study on Asymptomatic Sensitisation and Development of Allergic Rhinitis: High Negative Predictive Value of Allergological Testing
URI https://karger.com/doi/10.1159/000320758
https://www.ncbi.nlm.nih.gov/pubmed/21293149
https://www.proquest.com/docview/872440780
https://www.proquest.com/docview/883040005
Volume 155
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKhhAviMuAcqksxAMSZMvdDm8dGpq4TBNrUd8qJ7HLoCRTmz7AT-H_8L84viZhAw1eosi1ozbf13OO7e8cI_S0DAjEyVKKUyahFwcF8zIquMdTRv2ElyllSm1xlB5O4zezZDYY_OyoljZNvlt8vzCv5H9QhTbAVWbJ_gOy7qHQAPeAL1wBYbheCuOx1PnbXEm15GnzHE90regKXv-3r2dNrQuznki1emMEPEaE7DRDKiaViYELqa3_dCpVRUovJ6UgYAwXukT48Upu7ajbj2y54e0wZ0YnsnKH8YifW6V8u_DIOuVumRprqkDJZJXeOv9-XTYLzaqpEC091-vTvpFyJr7eLM2i0juYsz9_u9td11DZfXZdQ5tiPwC0Y137ZZfrNgj-PJl60rPfus6vIWrUtcb6dCLj2EN9dO55n5FkWmQZhRA_0dYxWjHAb_7SqRjV_CnJ5m7oFbQdEgjhwKySmZv3B7IEvtp0Nz_IFLiC9j03tBcWXf0iswBWUqfL1oCb0Ges_HkSpIKhyU10w8xi8FhT8hYa8Oo2uvbe6DTuoB9j3GHmC2x5iRUvcV3hLi9xj5cYmIA7vMS1wJaX2PLyJZasxJaVuGUlVqxsB1lWYsPKHTR9fTB5deiZU0C8IkpJ44WkyArCeRISThm4D5rnLFfaZ-EXYIHKosx9KhhhPI_hXcvNZZakRUgpTUQW3UVbVV3x-wiDgwry1Oeh8LM4jQgVeRRwQbM8TMIyz4bomQVhXpgS-fKkluX8HNRD9MR1PdN1YS7qtKORdF1s-6gHrPsY4mUaZ8QfImyRnoO5l3t4rOL1Zj2nBOJxCOv_1oVG0jP7yRDd0yRpny-j-yDOHlzm2z9E19v_5SO01aw2_DFE4E0-Uvweoe39g6PjD78A433ghw
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Prospective%2C+Clinical+Study+on+Asymptomatic+Sensitisation+and+Development+of+Allergic+Rhinitis%3A+High+Negative+Predictive+Value+of+Allergological+Testing&rft.jtitle=International+archives+of+allergy+and+immunology&rft.au=Bodtger%2C+Uffe&rft.au=Assing%2C+Kristian&rft.au=Poulsen%2C+Lars+K.&rft.date=2011-01-01&rft.issn=1018-2438&rft.eissn=1423-0097&rft.volume=155&rft.issue=3&rft.spage=289&rft.epage=296&rft_id=info:doi/10.1159%2F000320758&rft.externalDBID=n%2Fa&rft.externalDocID=10_1159_000320758
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1018-2438&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1018-2438&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1018-2438&client=summon